Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma

Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, Linda Nici, James W. Darnowski, Dario Barbone, Dean A. Fennell, Giovanni Gaudino, Camillo Porta, Luciano Mutti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science